1. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis

Reprod Sci, 2017, 24(11) p. 1551

DOI: 10.1177/1933719117702013

Citations as recorded by:

2. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: A meta-analysis

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017, 215 p. 234

DOI: 10.1016/j.ejogrb.2017.06.032

Citations as recorded by:

3. Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

IJMS, 2017, 18(8) p. 1651

DOI: 10.3390/ijms18081651

Citations as recorded by:

4. Association of Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Methylene Tetrahydrofolate Reductase Polymorphisms with Spontaneous Miscarriages

Acta Haematol, 2017, 138(2) p. 111

DOI: 10.1159/000478084

Citations as recorded by:

5. ‘To test or not to test’, the arguments for and against thrombophilia testing in obstetrics

Obstetric Medicine, 2017, 10(2) p. 61

DOI: 10.1177/1753495X17695696

Citations as recorded by:

6. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism is Associated with Reproductive Failure: Metabolic, Hormonal, and Immune Profiles

Am J Reprod Immunol, 2016, 76(1) p. 70

DOI: 10.1111/aji.12516

Citations as recorded by:

7. Toward optimal set of single nucleotide polymorphism investigation before IVF

Gynecological Endocrinology, 2016, 32 p. 11

DOI: 10.1080/09513590.2016.1232793

Citations as recorded by: